| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 07/28/2009 | CA2462453C Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
| 07/23/2009 | WO2009091561A1 Preparation and enantiomeric separation of 7-(3-pyridinyl)-1,7-diazaspiro[4.4] nonane and novel salt forms of the racemate and enantiomers |
| 07/23/2009 | US20090187020 Process And Intermediate For Preparation Of Donepezil |
| 07/23/2009 | US20090186886 Tricyclic 1,2,4-Triazine Oxides and Compositions for Therapeutic Use in Cancer Treatments |
| 07/23/2009 | US20090186871 Tyrosine kinase inhibitors |
| 07/23/2009 | US20090186867 Substituted Diketopiperazines As Oxytocin Antagonists |
| 07/22/2009 | EP2079736A1 Substituted triazoles useful as axl inhibitors |
| 07/22/2009 | EP1391456B1 2-iminoimidazole derivatives |
| 07/22/2009 | CN101490057A Compositions and methods of making a photoactive agent |
| 07/22/2009 | CN101490056A Nicotinic acetylcholine receptor ligands 101 |
| 07/22/2009 | CN101490055A Spirocyclic azaindole derivatives |
| 07/22/2009 | CN101486712A Method for synthesizing cyclic compound containing 2,5-dihydrofuran framework |
| 07/22/2009 | CN101486679A 5HT2c receptor modulators |
| 07/22/2009 | CN101486678A 5HT2C receptor modulators |
| 07/22/2009 | CN101486677A 5HT2c receptor modulators |
| 07/22/2009 | CN101486675A 2- and 2,5-substituted phenylketoenols |
| 07/22/2009 | CN101485664A 5HT2c receptor modulators |
| 07/22/2009 | CN100516066C Compounds for treating impaired fundic relaxation |
| 07/21/2009 | US7563904 (S)-4-{4-[N'-(2-Oxotetrahydropyran-3-iliden)hidrazino]benzyl}-1,3-oxazolidin-2-one; industrial scale production, purity, free of using toxic reagent |
| 07/21/2009 | US7563890 Synthons; nanomembranes |
| 07/21/2009 | US7563784 substituted 1,1,4-1l6-trioxo[1,2]thiazepan-4-ylamide-derived protease inhibitors which inhibit the likes of cathepsin K; treating osteoporosis, osteo- and rheumatoid arthritis and periodontal disease; inhibiting excessive cartilage or matrix degradation |
| 07/16/2009 | WO2009089312A1 (e)-n-{3- [1-(8-fluoro-11h-10-oxa-1-aza-dibenzo [a,d] cycl0hepten-5ylidene)-propyl]-phenyl }-methynsulfon amide as glucocorticoid receptor modulator for the treatment of rheumatoid |
| 07/16/2009 | WO2009087949A1 Compound having heterocyclic ring, and use thereof |
| 07/16/2009 | WO2009087379A2 Tetrahydrofuro (3, 2 -b) pyrrol- 3 -one derivatives as inhibitors of cysteine proteinases |
| 07/16/2009 | WO2009087153A1 Tricyclic nitrogen compounds and their use as antibacterial agents |
| 07/16/2009 | WO2009087127A1 Modulators for amyloid beta |
| 07/16/2009 | WO2009087058A1 Process for the preparation of asenapine and intermediate products used in said process |
| 07/16/2009 | WO2008138938A3 Process for the production of palladium supported catalysts for catalyzing heck, suzuki-miyaura sonogashira coupling and buchwald-hartwig reactions |
| 07/16/2009 | US20090181966 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 07/16/2009 | US20090181965 Modulators for amyloid beta |
| 07/16/2009 | US20090181955 Antibacterial Agents |
| 07/16/2009 | US20090181947 Bicyclic enamino(thio)carbonyl compounds |
| 07/16/2009 | CA2710800A1 Process for the preparation of asenapine and intermediate products used in said process |
| 07/16/2009 | CA2703824A1 Modulators for amyloid beta |
| 07/15/2009 | EP2078023A1 Tetrahydrofuro (3, 2-b) pyrrol-3-one derivatives as inhibitors of cysteine proteinases |
| 07/15/2009 | EP2078010A2 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/15/2009 | EP1863774A4 Heterocyclical chromophore architectures with novel electronic acceptor systems |
| 07/15/2009 | EP1805150A4 Heterocyclical chromophore architectures |
| 07/15/2009 | EP1745048A4 Simple stereocontrolled synthesis of salinosporamide a |
| 07/15/2009 | CN101484457A 4, 5-dihydro- [1, 2, 4] triazolo [4, 3-f] pteridines as protein kinase plk1 inhibitors for the treatment of proliferative disorders |
| 07/15/2009 | CN101484456A Process for the preparation of asenapine and intermediate products used in said process. |
| 07/15/2009 | CN101481377A Chemical semisynthesis process of irinotecan |
| 07/15/2009 | CN101481359A Cyclic protein tyrosine kinase inhibitors |
| 07/15/2009 | CN100513387C Novel dibenzo[B,F]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 07/14/2009 | US7560546 Tyrosine kinase inhibitors |
| 07/14/2009 | US7560458 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 07/14/2009 | US7560455 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 07/10/2009 | WO2008083367A2 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/10/2009 | WO2008083357A1 Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/10/2009 | CA2710234A1 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/10/2009 | CA2710230A1 Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/09/2009 | WO2009086264A1 Benzofuropyrimidinones as protein kinase inhibitors |
| 07/09/2009 | WO2009086028A2 Carbazole-containing materials in phosphorescent light emitting diodes |
| 07/09/2009 | WO2009083581A1 Carboxamide compounds and their use as calpain inhibitors |
| 07/09/2009 | WO2009018112A3 The use of novel coumarins as glutathione and thiol labels |
| 07/09/2009 | US20090176820 Polymorphic forms and process |
| 07/09/2009 | US20090176819 39-Desmethoxy-39-Methyl Derivatives of Rapamycin |
| 07/09/2009 | US20090176815 Novel Tricyclic Spiropiperidine Compounds, Their Synthesis and Their Uses as Modulators of Chemokine Receptor Activity |
| 07/09/2009 | US20090176771 Gyrase inhibitors and uses thereof |
| 07/09/2009 | US20090172899 Phenyl xanthene dyes |
| 07/09/2009 | CA2712358A1 Benzofuropyrimidinones as protein kinase inhibitors |
| 07/09/2009 | CA2710903A1 Carboxamide compounds and their use as calpain inhibitors |
| 07/08/2009 | EP2076518A1 Tricyclic spiro-oxindole derivatives and their uses as therapeutic agents |
| 07/08/2009 | EP1626970B1 Azabicycloalkane compounds as muscarinic receptor antagonists |
| 07/08/2009 | EP1592686B1 Gyrase inhibitors and uses thereof |
| 07/08/2009 | EP1495022B1 Diazabicyclo alkane derivatives with nk1 antagonistic activity |
| 07/08/2009 | EP1073647B1 12,13-cyclopropane epothilone derivatives |
| 07/08/2009 | EP0819000B1 Nodulisporic acid derivatives |
| 07/08/2009 | CN101479274A Pharmaceutical compounds |
| 07/08/2009 | CN101475575A Extraction of tetraodontoxin, and preparation thereof used in drug dependence of dolantin |
| 07/08/2009 | CN101475574A Camptothecin derivative, and preparation and use thereof |
| 07/08/2009 | CN100509815C Separation of monosomic tetrandrine from tetrandrine total alkaloid by adsorption resin method |
| 07/08/2009 | CN100509805C 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 07/07/2009 | US7557212 Tricyclic derivatives as LTD4 antagonists |
| 07/07/2009 | US7557208 5-hydroxy-7H-benzo[C]fluorene derivatives: 7,7-dimethyl-5-hydroxy-9-morpholino-7H-benzo[C]fluorene; intermediates for preparing indeno-fused naphthopyrans exhibiting reversible photochromism |
| 07/07/2009 | US7557206 Thermally reversible; absorption ratio greater than 2.3; cell method |
| 07/07/2009 | US7557118 4-Phenyl-6H-(1)Benzopyrano(4',3':4,5)pyrrolo(2,1-a)isoquinolin-6-one's and analogues, optionally mixed with acceptable carriers, excipients or diluents, used for treating multidrug resistant tumors, for inducing apoptosis and as immunology modulators |
| 07/07/2009 | US7557116 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1H-pyrano[2,3d 6,5-d′]dipyrimidyne and 10-aza-analogue thereof |
| 07/07/2009 | US7557115 Compounds for modulation of kinesins as anticancer agents with administering |
| 07/07/2009 | US7557114 Heterocyclic-substituted phenyl methanones |
| 07/07/2009 | US7557076 Organic catalyst with enhanced enzyme compatibility |
| 07/07/2009 | CA2450033C Viral polymerase inhibitors |
| 07/07/2009 | CA2378834C Pyrazinones, compositions containing such compounds |
| 07/02/2009 | WO2009081222A1 Substituted tricyclic pyridine or pyrimidine vanilloid receptor ligands |
| 07/02/2009 | WO2009037001A4 Novel tetrahydrofusedpyridines as histone deacetylase inhibitors |
| 07/02/2009 | WO2009010925A3 Annelated azaheterocyclic amides containing a pyrimidine fragment and method for the production and use thereof |
| 07/02/2009 | US20090170916 4,5-substituted pyrazole-3-carboxylic acids/esters/salts; D-amino acid oxidase (DAAO) inhibitors; increase D-Serine level; reduce level of toxic products of D-Serine oxidation; activate N-methyl-D-aspartate NMDA-glutamate receptors; neuropathic agent, schizophrenia, Alzheimer's, anaxia |
| 07/02/2009 | US20090170863 Acylated Spiropiperidine Derivatives as Melanocortin-4 Receptor Modulators |
| 07/02/2009 | US20090170835 Isoindoline derivatives |
| 07/01/2009 | EP2075250A2 Thrombin receptor antagonists |
| 07/01/2009 | EP2074092A2 Inhibitors of d-amino acid oxidase |
| 07/01/2009 | EP2073809A2 Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin |
| 07/01/2009 | EP2073807A1 Pharmaceutical combinations |
| 07/01/2009 | EP2073799A2 Novel agents of calcium ion channel modulators |
| 07/01/2009 | EP1503998B1 Heteroaryl substituted spirocyclic sufamides for inhibition of gamma secretase |
| 07/01/2009 | CN101472928A Polymorphic forms and process |
| 07/01/2009 | CN101469000A Vinyl monomer, polymer derived from such monomer, and a light-emitting device using such polymer |
| 07/01/2009 | CN101468995A Isoquinolinium compound, pharmaceutical composition containing the same, preparation and use thereof |
| 07/01/2009 | CN101468994A Isoquinolinium compound, pharmaceutical composition containing the same, preparation and use thereof |
| 07/01/2009 | CN101468993A Isoquinolinium compound, pharmaceutical composition containing the same, preparation and use thereof |